Profil dan Rasionalitas Penggunaan Obat Antihipertensi di Puskesmas Jawa Tengah

Asmaurini Pramudya, Rachmad Bagas Yahya Supriyono, Kristiyani Asuk, Jusman Jusman, Richa Yuswantina

Abstract


Hypertension is a major public health problem and a leading cause of cardiovascular morbidity and mortality. Rational use of antihypertensive drugs is essential to achieve optimal blood pressure control, particularly in primary healthcare settings. This study aimed to evaluate the profile and rationality of antihypertensive drug use at Pringapus and Cebongan Primary Health Centers, Central Java, during June–August 2025. An observational analytic study with a retrospective design was conducted using medical record data of hypertensive patients. The evaluation included patient characteristics, patterns of antihypertensive prescribing, and the rationality of drug use based on appropriate indication, drug selection, and dosage. Rationality was assessed according to the 2024 Guidelines for Hypertension Management in Primary Healthcare and the Drug Information Handbook 23rd edition. The results showed that most patients were elderly and female, with stage 1 hypertension being the most common diagnosis. Calcium channel blockers, particularly amlodipine, were the most frequently prescribed antihypertensive drugs. Overall, antihypertensive drug use demonstrated good rationality; however, several cases of inappropriate drug selection and dosage were identified. In conclusion, antihypertensive therapy at the studied primary healthcare centers was generally consistent with current guidelines, although continuous evaluation is required to optimize prescribing practices


Keywords


hypertension; antihypertensive drugs; rational drug use; community health centers; medical records

Full Text:

PDF

References


Aripin, Z. Z., Hikmah, S. N., & Rahmawati, R. A. (2024). Pola Penggunaan Obat Antihipertensi Terhadap Pasien Rawat Jalan Di Uptd Puskesmas Palimanan Cirebon Tahun 2022. Cendekia Journal of Pharmacy, 8(1), 10–16. https://doi.org/10.31596/cjp.v8i1.253.

Corbett, A. H., Dana, W. J., Fuller, M. A., Gallagher, J. C., Golembiewski, J. A., Gonzales, J. P., Lowe, J. F., Rybarczyk, A., Snoke, J., & Young, S. (2014). Drug Information Handbook with International Trade Names Index. Amerika.

Dagmar, Z. N., Lestari, D., & Rahayu, A. P. (2021). Evaluasi Profil Penggunaan Obat Antihipertensi Pada Pasien Hipertensi di Salah Satu Klinik Kota Bandung. Journal of Science, Technology, and Entrepreneurship, 3(1), 2657–1668.

Dinkes Prov. Jateng. (2020). Profil Dinas Kesehatan Jawa Tengah Tahun 2020. In Profil Kesehatan Provinsi Jawa Tengah (Vol. 3517463, Issue 24). https://ppid.jatengprov.go.id/rkpd-pemerintah-provinsi-jawa-tengah-tahun-2020/.

Ekaningtyas, A., Wiyono, W., & Mpila, D. (2021). Evaluation Of The Use Antihypertensive Drugs On Hypertension Patients At Kolongan Health Center North Minahasa Regency. Pharmacon, 10(4), 1215–1221.

Hidayah, K., Kundarto, W., & Farida, Y. (2017). Identification of Drug Interaction in Prescribing Drugs for Hypertension Patient with Diabetes Mellitus. Annual Pharmacy Conference, 3(1), 108–120.

Hidayaturahmah, R., & Syafitri, Y. O. (2021). Rasionalitas Penggunaan Obat Antihipertensi Di Puskesmas Rawat Inap Way Kandis Bandar Lampung Periode Januari-Juni 2021. Jurnal Farmasi Malahayati, 4(2), 227–236.

Kemenkes. (2023). Pedoman Pengendalian Hipertensi di Fasilitas Kesehatan Tingkat Pertama 2024. In Jakarta.

Kristanti, P. (2015). Effectiveness And Side Effects The Use Of Antihypertensive Drug Is Patients Of Hypertension In Puskesmas Kalirungkut. I.

Maimanah, S., Andarini, Y. D., & Kusumaningtyas, N. M. (2018). Identifikasi Drug Related Problems ( Drps ) Pada Pasien Diabetes Mellitus Tipe 2 Komplikasi Hipertensi Di Rsup Dr . Soeradji Tirtonegoro Klaten Tahun 2018. Pharmaceutical Journal Of Islamic Pharmacy, 4(2), 48–56.

Mila, Fakhruddin, & Irawan, Y. (2021). Evaluasi Kerasionalan Penggunaan Obat Antihipertensi Pada Pasien Hipertensi Di Instalasi Rawat Inap Rsud Sultan Imanuddin Pangkalan Bun 2018. Jurnal Borneo Cendekia, 5(1), 105–117.

Momuat, A. G. F., & Annisaa, E. (2023). Evaluasi Rasionalitas Penggunaan Antihipertensi Golongan Angiotensin Ii Receptor Blocker ( Arb ) Pada Pasien Penyakit Ginjal Kronis. Journal Of Research In Pharmacy, 3(1), 55–64.

Peng, X., Jin, C., Song, Q., Wu, S., & Cai, J. (2023). Year and Lifetime Risk of Cardiovascular Disease : Journal of the American Heart Association, 12, 1–29. https://doi.org/10.1161/JAHA.122.028762.

Permenkes RI. (2024). Peraturan Menteri Kesehatan Republik Indonesia Nomor 19 Tahun 2024 Tentang Penyelenggaraan Pusat Kesehatan Masyarakat.

Tiksnadi, A. A. S. S. M., Suling, F. R., Hustrini, N. M., Hidayat, R., & Danny, S. S. (2024). Panduan Pengenalan dan Tatalaksana Hipertensi Resisten Di Indonesia. In Perhimpunan Dokter Hipertensi Indonesia.

Tuloli, T. S., Rasdianah, N., & Tahala, F. (2021). Pola Penggunaan Obat Antihipertensi Pada Pasien Hipertensi. Indonesia Journal Of Pharmaceutical Education, 1(2), 127–135. 10.37311/ijpe.v1i3.11083.

Untari, E. K., Agilina, A. R., & Susanti, R. (2018). Evaluasi Rasionalitas Penggunaan Obat Antihipertensi di Puskesmas Siantan Hilir Kota Pontianak Tahun 2015. Pharmaceutical Sciences and Research, 5(1), 32–39. https://doi.org/10.7454/psr.v5i1.3870.




DOI: https://doi.org/10.52364/sehati.v6i1.165

Refbacks

  • There are currently no refbacks.


Copyright (c) 2026 Asmaurini Pramudya, Rachmad Bagas Yahya Supriyono, Kristiyani Asuk, Jusman Jusman, Richa Yuswantina

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.